Prostate cancer

Prostate cancer is the most frequently occurring cancer in men over the age of 50 and is the second most common cause of death from cancer after lung cancer. Learn more about the condition, its diagnosis and the different treatment options available.

Treatment for prostate cancer has improved in recent years, with an increasing focus on the individual patient and personalized medicine. Personalized, multidisciplinary therapeutic approaches provide better management of the pathology at all stages of progression.

A number of different treatment options are available, depending on the patient’s health and the stage of the cancer:

  • Surgery (radical prostatectomy) is a form of local treatment. In this operation, the surgeon removes the entire prostate gland and seminal vesicles. Surgery is generally indicated for some forms of high-risk localized prostate cancer or locally advanced prostate cancer.
  • External radiotherapy is a local cancer treatment to destroy the cancer cells in the prostate by external beam radiation (EBRT). It can be used alone for low-risk and medium-risk localized cancers, and in combination with hormone therapy for high-risk and locally advanced prostate cancers.
  • HIFU (High-intensity focused ultrasound) is a medical technique to destroy the tumor by thermal ablation.
  • Internal radiation therapy or brachytherapy is a technique to destroy the cancer cells by implanting radioactive pellets in the prostate that emit gamma rays.
  • Hormone therapy means prescribing Luteinising Hormone Releasing Hormone (LHRH) analogs for the patient. These hormones act on the production of sex hormones by the body. They slow disease progression by dramatically reducing testosterone levels.
  • Chemotherapy is a treatment option when the tumor does not respond to other conventional therapies.

After age 50

The most common cancer in men aged over 50

Second leading cause

of death from cancer

After age 70

Usually diagnosed after age 70

Last update 13/04/2017